Your browser doesn't support javascript.
loading
Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer: a 2015 position statement of the Italian Society of Endocrinology.
Pacini, F; Brianzoni, E; Durante, C; Elisei, R; Ferdeghini, M; Fugazzola, L; Mariotti, S; Pellegriti, G.
Afiliación
  • Pacini F; Department of Medical, Surgical and Neurological Sciences, University of Siena, Siena, Italy. pacini8@unisi.it.
  • Brianzoni E; Department of Endocrinology, University of Siena, Via Bracci, 53100, Siena, Italy. pacini8@unisi.it.
  • Durante C; Nuclear Medicine Unit, Ospedale Civile di Macerata, Macerata, Italy.
  • Elisei R; Department of Internal Medicine and Medical Specialties, University of Rome Sapienza, Rome, Italy.
  • Ferdeghini M; Endocrine Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Fugazzola L; Nuclear Medicine Unit, University of Verona, Verona, Italy.
  • Mariotti S; Endocrine Unit, Fondazione IRCCS Ca' Granda Policlinico, Milan, Italy.
  • Pellegriti G; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
J Endocrinol Invest ; 39(3): 341-7, 2016 Mar.
Article en En | MEDLINE | ID: mdl-26264386
ABSTRACT
UNLABELLED Post-surgical ablation of thyroid remnant with radioactive iodine (RAI) in differentiated thyroid cancer (DTC) is aimed to destroy any thyroid remnant in the thyroid bed (remnant ablation) and any microscopic foci of cancer cells eventually present within the thyroid remnant (adjuvant therapy). The present text is an attempt to offer practice guidelines for the indication of thyroid ablation and the preparation of DTC patients considering the latest achievement in the field and the changing epidemiology of DTC observed in the last 10 years.

METHODOLOGY:

The executive committee of the Italian Society of Endocrinology appointed a task force of thyroid cancer expert including Nuclear Medicine Physicians and Endocrinologists to provide a consensus on the post-surgical ablation in thyroid cancer patients. The task force had no conflict of interest and had no commercial support. A number of specific topics were selected and the members selected relevant papers by searching in the Pubmed for articles published from 2000 to January 2015. Selected studies were categorized by level of evidence, and the recommendations were graded according to the level of evidence as high (A), moderate (B), or low (C).
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Adenocarcinoma / Diferenciación Celular / Guías de Práctica Clínica como Asunto / Ablación por Catéter Tipo de estudio: Guideline Límite: Humans País/Región como asunto: Europa Idioma: En Revista: J Endocrinol Invest Año: 2016 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Adenocarcinoma / Diferenciación Celular / Guías de Práctica Clínica como Asunto / Ablación por Catéter Tipo de estudio: Guideline Límite: Humans País/Región como asunto: Europa Idioma: En Revista: J Endocrinol Invest Año: 2016 Tipo del documento: Article País de afiliación: Italia